Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. (Nasdaq: HSAQ) is a biomedical company operating in the healthcare and medical device sector, with a focus on cardiovascular therapeutic technologies. The company filed an 8-K current report with the SEC on June 23, 2026, disclosing a material event under accession number 0001104659-26-076845. Orchestra BioMed entered public markets through the SPAC route and has been active in the life sciences capital markets space. Its therapeutic pipeline centers on device-based approaches to cardiovascular disease management. For complete filing details, sponsor information, deal history, and real-time SPAC data on Orchestra BioMed Holdings and hundreds of other vehicles, sign up for full access at SpacDesk.